Grace Therapeutics, Inc. (GRCE)
Operating Income
-$25.69M
TTM · Period ending: · USD
GRCE Operating Income
Latest reported-$25.69Mperiod ending
Latest reported-$25.69Mperiod ending
GRCE TTM Operating Income (-$1.28M → -$25.69M)
TTM operating income
High-resolution chart · PNG
GRCE operating income history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Income (USD) |
|---|---|
| -25,687,618 | |
| -12,987,618 | |
| -14,510,560 | |
| -16,476,899 | |
| -17,780,627 | |
| -21,478,174 | |
| -21,373,155 | |
| -20,079,944 | |
| -18,081,993 | |
| -17,194,941 | |
| -64,261,956 | |
| -65,932,245 | |
| -68,207,196 | |
| -68,396,914 | |
| -22,403,407 | |
| -22,401,685 | |
| -21,813,371 | |
| -20,533,529 | |
| -18,661,855 | |
| -16,161,963 | |
| -25,866,535 | |
| -28,636,444 | |
| -30,182,187 | |
| -33,126,038 | |
| -25,156,780 | |
| -25,582,500 | |
| -31,308,777 | |
| -33,026,039 | |
| -34,849,923 | |
| -34,388,783 | |
| -28,930,202 | |
| -25,162,367 | |
| -20,618,262 | |
| -15,786,385 | |
| -12,212,876 | |
| -9,989,006 | |
| -8,722,946 | |
| -7,566,483 | |
| -7,666,251 | |
| -7,425,917 | |
| -7,256,571 | |
| -7,408,156 | |
| -8,026,815 | |
| -9,573,278 | |
| -10,211,749 | |
| -10,156,496 | |
| -10,689,763 | |
| -10,603,136 | |
| -9,784,005 | |
| -9,928,446 | |
| -8,444,088 | |
| -7,106,957 | |
| -6,759,602 | |
| -6,711,600 | |
| -7,217,600 | |
| -7,226,912 | |
| -6,698,561 | |
| -5,965,143 | |
| -4,594,368 | |
| -3,472,832 | |
| -2,942,424 | |
| -2,346,479 | |
| -1,952,941 | |
| -1,762,588 | |
| -1,514,625 | |
| -1,283,514 |